Nicholas Singer has been named as a new member of Brooklyn ImmunoTherapeutics' Board of Directors.

Waltham-based biologics startup Comera Life Sciences is trading on the Nasdaq after a reverse merger with OTR Acquisition Corp.

Comera Life Sciences Holdings, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced the completion of its business combination with OTR Acquisition Corp.

As IntegriCo continues to expand and restructure as a company, Nicholas Singer was named executive chairman responsible for day-to-day management. He expresses his excitement for future growth and benefit for the environment.